Our department is mainly concerned with research and management in the fields of endemic liver and gastrointestinal diseases that is most worrisome to our community.
According to HCV Advocate, the main cause of exposure in Egypt appears to be due to
inadequate infection control practices and injection therapy such as blood transfusions.
Lacking in infrastructure to deal with the virus, Egypt suffers from a particularly high
morbidity and mortality rate, with 40,000 dying from the disease each year. It is estimated
that roughly 15 million Egyptians currently suffer from Hepatitis C. Every year there are
170,000 to 200,000 new HCV cases.
Kafr ElSheikh governorate is one of the highest 6 spots all over Egypt in HCV incidence and
prevalence that has been deprived from proper medical health care facilities.
Our department will include 100 beds inpatient ward and a specialised viral hepatitis clinic
that well provide treatment with the new directly acting antiviral drugs according to the latest
guidelines.
The World Health Organisation (WHO) has found that Egypt has the highest prevalence of
the Hepatitis C virus (HCV) in the world, with approximately 22 percent of Egyptian blood
donors testing positive for the deadly disease.
ERCP and EUS, that we are aiming to develop and provide training for young endoscopists.